What is the difference between stage I and stage II pressure ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Difference Between Stage 1 and Stage 2 Pressure Ulcers

Stage 1 pressure ulcers present with intact skin and non-blanchable erythema over a bony prominence, while Stage 2 pressure ulcers involve partial-thickness skin loss with exposed dermis but no deeper tissue exposure. 1

Stage 1 Pressure Ulcer Characteristics

Skin Integrity:

  • The skin remains completely intact with no break in the epidermis 2, 3
  • This is the defining feature that distinguishes Stage 1 from Stage 2 1

Color Changes:

  • Non-blanchable erythema is the hallmark presentation in 75% of cases 2
  • The affected area does not blanch (turn white) when pressed, though research shows blanching can sometimes be present contrary to traditional teaching 2
  • In darkly pigmented skin, the area may appear normal in color in 11.4% of cases, making visual assessment alone insufficient 2

Temperature Differences:

  • The affected area may be warmer or cooler than adjacent skin 4
  • Cool areas (average -1.2°C compared to surrounding skin) are 31.8 times more likely to progress to tissue necrosis than warm areas 4
  • This temperature difference is a critical early warning sign that visual inspection alone may miss 4

Texture and Sensation:

  • The area may feel boggy, indurated (firm), or painful to touch 2
  • These tactile findings are particularly important in darkly pigmented skin where color changes may be subtle 2, 5

Dermoscopic Features:

  • When examined with dermoscopy, Stage 1 ulcers show petechial dots and telangiectatic streaks in 90% of cases 6
  • These microscopic vascular changes persist under compression and help confirm the diagnosis 6

Stage 2 Pressure Ulcer Characteristics

Skin Integrity:

  • Partial-thickness skin loss with exposed dermis is the defining feature 1
  • The epidermis is broken, creating a visible wound 3
  • The wound bed is viable, pink or red, and moist 3

Wound Appearance:

  • Presents as a shallow open ulcer without slough or eschar 3
  • May also present as an intact or ruptured serum-filled blister 3
  • The dermis is visible but deeper tissues (subcutaneous fat, muscle, tendon, bone) are not exposed 1

Surrounding Skin:

  • May have erythema extending beyond the wound edges 6
  • Dermoscopic examination of this surrounding redness shows the same petechial dots and telangiectatic streaks seen in Stage 1 ulcers 6

Critical Clinical Distinctions

The Progression Pathway:

  • Stage 1 represents the earliest detectable tissue damage with intact skin acting as a protective barrier 3
  • Once the skin breaks and dermis is exposed, the ulcer has progressed to Stage 2 1
  • This distinction is crucial because Stage 2 ulcers require different wound care approaches including appropriate dressings 7

Management Implications:

  • Stage 1: Focus on immediate pressure relief with repositioning every 2-4 hours, advanced static air mattresses, and preventing progression 7, 8
  • Stage 2: Apply hydrocolloid or foam dressings (changed every 1-7 days based on exudate) in addition to all Stage 1 interventions 7
  • Both stages benefit from protein supplementation (30 energy percent protein) to support tissue healing 7

Common Pitfalls to Avoid

Assessment Errors:

  • Do not rely solely on visual inspection for non-blanchable erythema, especially in darkly pigmented skin where color changes may be absent or subtle 2, 5
  • Always assess temperature differences and tactile changes (bogginess, induration, pain) as these may be the only detectable signs in dark skin 2, 4
  • Do not assume all intact skin with discoloration is Stage 1—cool temperature combined with non-blanching indicates high risk for progression to deep tissue injury 4

Documentation Requirements:

  • Specify the anatomic location (e.g., sacrum, heel) and document all findings including color, temperature, texture, and patient symptoms 1
  • For Stage 2, document wound dimensions, exudate characteristics, and surrounding skin condition 1

Staging Limitations:

  • Do not attempt to stage wounds covered by eschar or slough—these must be classified as "unstageable" until debrided 1
  • The presence of a blister does not automatically mean Stage 2; intact serum-filled blisters over pressure areas are classified as Stage 2, but blood-filled blisters may indicate suspected deep tissue injury 3

References

Guideline

Pressure Injury Classification and Documentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pressure ulcers: prevention, evaluation, and management.

American family physician, 2008

Research

Dermoscopic evaluation of erythema associated with pressure ulcers.

International journal of dermatology, 2011

Guideline

Pressure Ulcer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pressure Ulcer Prevention and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What E/M code is appropriate for a patient with an unstageable pressure ulcer and possible infection?
What is the most important diagnostic test for a diabetic patient with a plantar foot ulcer and nearly diminished sensation?
What is the management of a sacral ulcer with discharge, necrotic area, and exposed fat in an Intensive Care Unit (ICU) elderly patient?
What is the best wound care treatment for a patient with a new dark spot on the great toe, suggestive of a pressure ulcer, in a Skilled Nursing Facility (SNF) setting?
What factors contribute to the development of Pressure Ulcers (PU) in healthcare units and what difficulties exist in preventing them, along with suggestions for improvement?
How should I treat an uncomplicated outpatient urinary tract infection caused by Escherichia coli in an elderly female?
What are the differential diagnoses for a 15‑year‑old adolescent with post‑prandial abdominal pain?
What is the recommended Bactrim double‑strength (sulfamethoxazole 800 mg + trimethoprim 160 mg) dosing for uncomplicated urinary‑tract infection in a non‑pregnant adult, and how should the dose be adjusted for impaired renal function?
Can escitalopram be prescribed for depression or anxiety in a patient with muscular dystrophy, and what dosing and monitoring are recommended?
How should I evaluate and manage a patient with an elevated creatine kinase of about 1000 U/L and joint pain?
What is the appropriate D‑mannose dosage for preventing recurrent uncomplicated urinary tract infections in an otherwise healthy non‑pregnant adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.